Crystal Jin
Co-Founder & Chief Executive Officer Bound Therapeutics
Seminars
Friday 29th January 2027
Establishing Multi-Target RNAi Strategies for Complex Tumour Biology
3:00 pm
- Exploring dual and multi-gene silencing approaches designed to overcome pathway redundancy
- Addressing tumour adaptation and resistance mechanisms through combinatorial targeting
- Improving treatment responses across heterogeneous cancer populations
